APA
Woyach J. A., Ruppert A. S., Heerema N. A., Zhao W., Booth A. M., Ding W., Bartlett N. L., Brander D. M., Barr P. M., Rogers K. A., Parikh S. A., Coutre S., Hurria A., Brown J. R., Lozanski G., Blachly J. S., Ozer H. G., Major-Elechi B., Fruth B., Nattam S., Larson R. A., Erba H., Litzow M., Owen C., Kuzma C., Abramson J. S., Little R. F., Smith S. E., Stone R. M., Mandrekar S. J. & Byrd J. C. (20190111). Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL. : The New England journal of medicine.
Chicago
Woyach Jennifer A, Ruppert Amy S, Heerema Nyla A, Zhao Weiqiang, Booth Allison M, Ding Wei, Bartlett Nancy L, Brander Danielle M, Barr Paul M, Rogers Kerry A, Parikh Sameer A, Coutre Steven, Hurria Arti, Brown Jennifer R, Lozanski Gerard, Blachly James S, Ozer Hatice G, Major-Elechi Brittny, Fruth Briant, Nattam Sreenivasa, Larson Richard A, Erba Harry, Litzow Mark, Owen Carolyn, Kuzma Charles, Abramson Jeremy S, Little Richard F, Smith Scott E, Stone Richard M, Mandrekar Sumithra J and Byrd John C. 20190111. Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL. : The New England journal of medicine.
Harvard
Woyach J. A., Ruppert A. S., Heerema N. A., Zhao W., Booth A. M., Ding W., Bartlett N. L., Brander D. M., Barr P. M., Rogers K. A., Parikh S. A., Coutre S., Hurria A., Brown J. R., Lozanski G., Blachly J. S., Ozer H. G., Major-Elechi B., Fruth B., Nattam S., Larson R. A., Erba H., Litzow M., Owen C., Kuzma C., Abramson J. S., Little R. F., Smith S. E., Stone R. M., Mandrekar S. J. and Byrd J. C. (20190111). Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL. : The New England journal of medicine.
MLA
Woyach Jennifer A, Ruppert Amy S, Heerema Nyla A, Zhao Weiqiang, Booth Allison M, Ding Wei, Bartlett Nancy L, Brander Danielle M, Barr Paul M, Rogers Kerry A, Parikh Sameer A, Coutre Steven, Hurria Arti, Brown Jennifer R, Lozanski Gerard, Blachly James S, Ozer Hatice G, Major-Elechi Brittny, Fruth Briant, Nattam Sreenivasa, Larson Richard A, Erba Harry, Litzow Mark, Owen Carolyn, Kuzma Charles, Abramson Jeremy S, Little Richard F, Smith Scott E, Stone Richard M, Mandrekar Sumithra J and Byrd John C. Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL. : The New England journal of medicine. 20190111.